9 METERS BIOPHARMA, INC.【NMTRQ】
Market cap
$1.45K
P/E ratio
| Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | |
| Research and development | - | - | - | - | 11 | 22 | 31 |
| Research and Development in Process | - | - | - | - | 32 | 5 | - |
| General and administrative | 4 | 5 | 11 | 11 | 11 | 10 | 11 |
| Total operating expenses | 7 | 9 | 18 | 26 | 61 | 37 | 42 |
| Loss from operations | -6 | -9 | 18 | 26 | -60,877,758 | -36,761,919 | -42,017,051 |
| Interest income | - | - | - | - | - | - | 501,228 |
| Interest expense | 1 | 0 | 6 | 2 | 4 | 47,188 | 3 |
| Gain (Loss) on Extinguishment of Debt | - | 0 | - | -1,049,166 | - | - | -20,303 |
| Derivative, Gain (Loss) on Derivative, Net | - | - | 50,000 | 1 | 771,000 | 7,000 | 437,000 |
| Total other income (expense), net | - | 1 | -5,938,211 | -1,500,247 | -618,731 | -17,481 | -1,749,364 |
| Loss before income taxes | -6 | -8 | -24,162,279 | -27,048,808 | -61,496,489 | -36,779,400 | -43,766,415 |
| Income tax benefit | 0 | - | - | - | - | - | - |
| Net loss | -6 | -8 | -24,162,279 | -27,048,808 | -61,496,489 | -36,779,400 | -43,766,415 |
| Earnings Per Share, Basic | - | - | - | - | - | -0.15 | -3.38 |
| Earnings Per Share, Diluted | - | - | - | - | - | -0.15 | -3.38 |